-
Company Insights
Innovation and Patenting activity of Daily Mail & General Trust plc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Daily Mail & General Trust plc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The...
-
Analyst Opinions
NewElectricals Market Size, Trends and Analysis by Regional and Category Performance, Brands and Forecast to 2028
This report provides an overview of the global electricals market which includes analysis, drivers, inhibitors, market forecasts, retailers and trends in the global electricals market 2023-2028. The global electricals market experienced a CAGR of 2.4% between 2018 and 2023, driven by rising per capita incomes, product innovation, and consumers’ increasing dependence on electronic devices due to their convenience and integration into modern daily life. Due to its large population of young and tech-savvy consumers, the Asia Pacific region held the...
-
Thematic Analysis
NewPublishing Sector Scorecard, Q1 2024 Update – Thematic Intelligence
AI continues to disrupt the publishing industry, and thus, the theme appears to be where the most progress is happening. To cope with the winds of change, publishers are holding AI-related conferences, building AI teams, and enhancing their offerings with AI, including launching new AI features like chatbots to improve user experiences.
-
Product Insights
Likelihood of Approval Analysis for Anxiety Disorders
Overview How likely is it that the drugs in Anxiety Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anxiety Disorders Overview Anxiety disorders are a group of mental health conditions...
-
Product Insights
Likelihood of Approval Analysis for Bipolar Disorder (Manic Depression)
Overview How likely is it that the drugs in Bipolar Disorder (Manic Depression) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bipolar Disorder (Manic Depression) Overview Bipolar disorder, previously known as...
-
Product Insights
Likelihood of Approval Analysis for Psychosis
Overview How likely is it that the drugs in Psychosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Psychosis Overview Psychosis is a condition that affects the mind and causes a...
-
Product Insights
Likelihood of Approval Analysis for Major Depressive Disorder
Overview How likely is it that the drugs in Major Depressive Disorder will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Major Depressive Disorder Overview Major Depressive Disorder (MDD) is a common...
-
Product Insights
Likelihood of Approval Analysis for Muscle Spasticity
Overview How likely is it that the drugs in Muscle Spasticity will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Muscle Spasticity Overview Muscle spasticity is a condition that causes muscles to...
-
Product Insights
Likelihood of Approval Analysis for Arthritis Pain
Overview How likely is it that the drugs in Arthritis Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Arthritis Pain Overview Arthritis pain stems from inflammation in joints, causing discomfort,...
-
Product Insights
Likelihood of Approval Analysis for Autism Spectrum Disorder (ASD)
Overview How likely is it that the drugs in Autism Spectrum Disorder (ASD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Autism Spectrum Disorder (ASD) Overview Autism Spectrum Disorder (ASD) is...